1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body's immune system attacking its own joints. RA can strike quickly at any age—but ...
Jul 3, 2025
0
21
A new study by scientists at the University of Colorado Anschutz Medical Campus reveals that joint tissue from patients with early-stage rheumatoid arthritis often have high levels of a protein called granzyme used by the ...
Jul 2, 2025
0
7
It's a debilitating disease that affects more than 500,000 Australians, but new research from the University of South Australia is offering fresh hope to people living with rheumatoid arthritis (RA).
Jul 1, 2025
0
96
Kennedy researchers have uncovered new clues about how immune memory exacerbates inflammation in rheumatoid arthritis, which could lead to better ways to control the disease.
Jun 30, 2025
0
1
A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of Medicine at the University ...
Jun 25, 2025
0
0
Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues.
Jun 18, 2025
0
32
The most comprehensive analysis of rheumatoid arthritis data to date reveals that demographic changes and uneven health infrastructure have exacerbated the rheumatoid arthritis burden since 1980 and shows global disparities ...
Jun 16, 2025
0
5
When receiving a diagnosis of a rheumatic musculoskeletal disease (RMD), people need a lot of information. Some need it all at once, while others may prefer to receive it in smaller portions or like to spread it out. This ...
Jun 13, 2025
0
0
Rheumatic musculoskeletal diseases (RMD) have an important impact on quality of life, and represent an economic burden to society. EULAR—The European Alliance of Associations for Rheumatology—has emphasized the role of ...
Jun 13, 2025
0
0
Regulatory authorities issued precautionary recommendations following the ORAL Surveillance trial, which demonstrated an elevated risk of cancer with tofacitinib, compared to TNF inhibitors (TNFi).
Jun 12, 2025
0
0
